一项比较研究vildagliptin品牌及其通用等价物使用溶解试验作为质量控制测量工具的比较研究
Ghadah H Altoum1, Fouza K Al-Enazi1, Mubarl M Abudahash1
1Research and Laboratories Sector, National Drug and Cosmetic Control Laboratories (NDCCL), Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Scientific reports
|February 1, 2024
概括
两种通用vildagliptin50毫克片显示了与品牌产品的药物等价性. 在体外溶解试验证实了可比的质量和溶解概况,符合抗糖尿病药物的可接受标准.
科学领域:
- 制药科学 制药科学
- 药理动力学 药理动力学
- 药品质量控制 药品质量控制
背景情况:
- 在市场上销售的药物,包括vildagliptin,必须符合有效性和患者安全性的严格质量标准.
- 维尔达格利普丁是一种重要的抗糖尿病药物,用于各种糖尿病治疗方案.
- 由于对某些市场药物的质量存在担忧,因此需要对仿制药替代品进行严格的评估.
研究的目的:
- 为了评估两种通用vildagliptin 50 mg片剂配方的药物等价性.
- 为了比较通用vildagliptin产品与品牌参考产品 (Galvus 50 mg) 的体外溶解概况.
主要方法:
- 使用体外溶解测试作为主要的质量控制方法.
- 从仿制药片和参考产品中确定了vildagliptin的溶解概况.
- 使用相似性因子分析溶解数据,以评估比较性能.
主要成果:
- 所有测试的通用维达格利普丁样本都表现出与参考药物相似的溶解行为.
- 所有样品在15分钟内完全溶解药物,符合可接受的标准.
- 类似性因子分析表明,仿制品和品牌维达格利普丁产品之间具有可比的溶解配置.
结论:
- 研究的仿制维达格利普丁50毫克片在药学上与品牌产品相当.
- 在体外溶解方案有效评估了仿制抗糖尿病药物的质量和可比性.
- 这项研究支持这些通用vildagliptin配方用于糖尿病管理的可靠性.
相关概念视频
Bioequivalence: Overview
1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
134
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
134
Factors Influencing Drug Absorption: Drug Dissolution
505
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
505
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
309
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
309
Factors Affecting Dissolution: Particle Size and Effective Surface Area
849
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
849
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.4K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.4K


